The administration of U.S. President Donald Trump has announced plans to expand drilling for crude oil and natural gas within the Alaskan ...

H.C. Wainwright tells investors that the firm’s investment thesis on Praxis Precision (PRAX) Medicines has been based on the company’s “innovative” epilepsy portfolio, so today’s news ...

Wall Street expects a year-over-year increase in earnings on lower revenues when Praxis Precision Medicines, Inc. (PRAX) reports results for the quarter ended December 2024. While this widely ...

Sign up for the Marketplace newsletter to get the day’s biggest business stories, our economic analysis, and explainers to help you live smarter, straight to your ...

Removing 76 gasoline ads 'would send the message that it's time to end our embrace of polluting fossil fuels,' Senate ...

MLB, Topps and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB logos on their jerseys that will then be used to create trading cards.

BOSTON, March 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of ...

2-Year U.S. Treasury Note Continuous Contract $103.508 0.020 0.02% 5-Year U.S. Treasury Note Continuous Contract $107.969 0.047 0.04% 10-Year U.S. Treasury Note Continuous Contract $111.125 0.125 ...

Looking at options history for Praxis Precision Medicine (NASDAQ:PRAX) we detected 39 trades. If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened ...

2-Year U.S. Treasury Note Continuous Contract $103.508-0.027-0.03% 5-Year U.S. Treasury Note Continuous Contract $107.961-0.055-0.05% 10-Year U.S. Treasury Note Continuous Contract $111.094-0.078 ...

Praxis Precision Medicines (NASDAQ:PRAX – Free Report) had its price objective trimmed by Truist Financial from $175.00 to $85.00 in a research note released on Monday morning,Benzinga reports.

Praxis Precision Medicines (NASDAQ:PRAX – Free Report) had its price objective trimmed by Robert W. Baird from $117.00 to $73.00 in a research report report published on Monday morning ...